We sat down with Memorial Sloan Kettering Cancer Center's Dr. Richard Koche and Dr. Iestyn Whitehouse to learn how epigenetics is revolutionizing rare cancer treatment and why Cycle for Survival funding is so important for their research. Help us continue this vital work by donating before April 15: https://lnkd.in/eReURsF8
